Novartis' Sandoz founds new initiative to expand biosimilar use more globally

Sandoz on Tuesday launched a new initiative called “Act4Biosimilars,” led by a steering committee that includes Sandoz exec Michael Wiechmann, the company’s global head of medical affairs.